Step 1
See your doctor to get a request
See your doctor to get a request form for testing and discuss Pharmacogenomic (PGx) testing with them.
Your genetic make up (your DNA) provides a crucial role in how your body responds to medication.
Pharmacogenomic (PGx) DNA testing empowers you and your healthcare provider to develop a tailored treatment plan for maximum effectiveness.
Taken medications in the past and found them not to work?
Depending on your unique genetic makeup, you may process a medication:
This is because we all process medications differently.
If we are all given the same medication at the same dose, we react in four different ways:
By testing our DNA, we can work out how we may react to each medication.
Thus testing can help your doctor determine the right medication at the right dose for you.
Pharmacogenomic testing is a powerful tool that empowers both you and your doctor to make informed, personalized decisions about your medication, helping you achieve better health outcomes quickly and safely.
Step 1
See your doctor to get a request form for testing and discuss Pharmacogenomic (PGx) testing with them.
Step 2
Prepay for your test online here or contact our Customer Care team on 1800 822 999. Note that Medicare does NOT cover the cost of testing.
Write your receipt number on the request form and get your blood collected at your closest Healius Pathology Network* collection centre.
Step 3
Your results will be sent to your doctor approximately 2 weeks after having your blood collected. Please discuss them with your doctor and ask for a copy of your results.
Pharmacogenomics is the study of the role that DNA variants play in drug efficacy. The DNA variants may either be inherited, and part of an individual’s inherited genetic make-up, or may be acquired in a person’s tumour (non-heritable) and can be used to predict drug responses or the likelihood of adverse drug reactions.
In addition to specific tests available for the enzymes thiopurine S-methyltransferase (TPMT) and glucuronyltransferase (UGT1A1), the Pharmacogenomic (PGx) Multi panel covers enzymes involved in breaking down medications used in the mental health area and the pain area as well as a wide range of other medications.
In the case of cancer treatment, the mutations acquired in a person’s tumour (non-heritable) may make the tumour more sensitive or resistant to treatment targeted gene, or gene pathway, specific treatment.
Providing the patient with the right dose of the right medicine is the aim of personalised medicine. Variation in an individual’s genetic makeup compared to others in the general population can affect their response to medications because some of these variations affect drug metabolic pathways. In some cases, this may result in sub-optimal therapeutic levels, or conversely, toxic adverse effects.
Step 1
Discuss Pharmacogenomic (PGX) testing with your patient and provide a request form. Ensure you note all relevant medications patient has been on in the past and is currently on as well as those being considered.
Step 2
Patients are required to prepay for their PGx Multi here and note their receipt number of the request form. They then attend their most convenient collection centre with their signed request form.
Step 3
Results are delivered to you by your preferred method approximately 2 weeks after the patient has their blood collected.